Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-20

Clinical Trial Update: Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating ultrasonic ablation for secondary hyperparathyroidism in chronic kidney disease patients; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ultrasonic Ablation

Snippet

Sponsor: Dongliang Zhang, MD | Conditions: Hyperparathyroidism, Disorders of Parathyroid Gland | NA | Status: COMPLETED | Results posted: 2015-11-20